KAIROS PHARMA, LTD. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
KAIROS PHARMA, LTD. (KAPA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.50% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-31
- KAIROS PHARMA, LTD. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 0.50%.
- KAIROS PHARMA, LTD. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.50% 10-K · filed 2026-03-31 | 4.40% 10-K · filed 2025-04-15 |
| 2023-12-31 | 0.00% 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |